Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists

I. I. Dedov; N. G. Mokrysheva; M. V. Shestakova; T. V. Nikonova; A. Yu. Mayorov; G. R. Galstyan; M. Sh. Shamhalova; V. O. Barysheva; A. S. Ametov; M. B. Antsiferov; A. Yu. Babenko; T. P. Bardymova; F. V. Valeeva; A. A. Vachugova; E. N. Grineva; T. Yu. Demidova; T. P. Kiseleva; M. A. Kunicyna; T. N. Markova; A. M. Mkrtumyan; N. A. Petunina; L. A. Ruyatkina; V. V. Saluhov; L. A. Suplotova; E. L. Hadarceva; Yu. Sh. Halimov

doi:10.14341/DM12873-10002

For citations:

Dedov I.I., Mokrysheva N.G., Shestakova M.V., Nikonova T.V., Mayorov A.Yu., Galstyan G.R., Shamhalova M.Sh., Barysheva V.O., Ametov A.S., Antsiferov M.B., Babenko A.Yu., Bardymova T.P., Valeeva F.V., Vachugova A.A., Grineva E.N., Demidova T.Yu., Kiseleva T.P., Kunicyna M.A., Markova T.N., Mkrtumyan A.M., Petunina N.A., Ruyatkina L.A., Saluhov V.V., Suplotova L.A., Hadarceva E.L., Halimov Yu.Sh. Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists. Diabetes mellitus. 2022;25(1):27-49. (In Russ.) https://doi.org/10.14341/DM12873

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy